Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines
Marit J. van Gils, A. H. Ayesha Lavell, Karlijn van der Straten, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18

Showing 18 citing articles:

The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2
Jeffrey P. Townsend, Hayley B. Hassler, Pratha Sah, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 31
Open Access | Times Cited: 69
Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection
Behnam Keshavarz, Nathan E. Richards, Lisa J. Workman, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study
Marta Selma‐Royo, Christine Bäuerl, Desirée Mena‐Tudela, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 47
COVID-19 Vaccine Effectiveness in Preventing SARS-CoV-2 Infection and Antibody Response Among Health Care Workers in Base Hospital Wathupitiwala, Sri Lanka
WAMP Samaranayake
(2025), pp. 1-8
Closed Access
Validation of neutralizing antibody titers for estimating vaccine effectiveness for the Omicron SARS-CoV-2 variant, BA.1
Billy J. Gardner, A. Marm Kilpatrick
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 39
Post-vaccination T cell immunity to omicron
Henning Jacobsen, Viviana Cobos Jiménez, Ioannis Sitaras, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Optimization of Anti-SARS-CoV-2 Neutralizing Antibody Therapies: Roadmap to Improve Clinical Effectiveness and Implementation
Karlijn van der Straten, Marit J. van Gils, Steven W. de Taeye, et al.
Frontiers in Medical Technology (2022) Vol. 4
Open Access | Times Cited: 17
Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern
Danique M.H. van Rijswijck, Albert Bondt, Max Hoek, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany
Alex Dulovic, Barbora Kessel, Manuela Harries, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike
Yme U. van der Velden, Marloes Grobben, Tom G. Caniels, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Third doses of COVID-19 vaccines reduce infection and transmission of SARS-CoV-2 and could prevent future surges in some populations: a modeling study
Billy J. Gardner, A. Marm Kilpatrick
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 17
Immunogenicity and reactogenicity of booster vaccinations after Ad26.COV2.S priming
Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 15
Increased risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variant compared to Alpha variant in vaccinated individuals
Stijn P. Andeweg, Harry Vennema, Irene Veldhuijzen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 14
Current Review of Delta Variant of SARS-CoV-2
Selia Chowdhury, Mehedi Hasan Bappy, Samia Chowdhury, et al.
European Journal of Medical and Health Sciences (2021) Vol. 3, Iss. 6, pp. 23-29
Open Access | Times Cited: 12
Broad neutralization against SARS-CoV-2 variants induced by a next-generation protein vaccine V-01
Shiyu Sun, Xi Chen, Jingjing Lin, et al.
Cell Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 10
An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants
Wenjuan Du, Daniel L. Hurdiss, Dubravka Drabek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Comparative magnitude and persistence of SARS-CoV-2 vaccination responses on a population level in Germany
Alex Dulovic, Barbora Kessel, Manuela Harries, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
IgG1 responses following SARS-CoV-2 infection are polyclonal and highly personalized, whereby each donor and each clone displays a distinct pattern of cross-reactivity against SARS-CoV-2 variants
Danique M.H. van Rijswijck, Albert Bondt, Max Hoek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top